£1.7M
The funding from the Development Bank of Wales will help the university spinout commercialise its rapid diagnostic tests for urinary tract infections.
LS
Llusern Scientific
Llusern Scientific develops rapid molecular diagnostic testing systems for human and animal healthcare.
Cardiff, UK—Founded 2020
£1.7MTotal raised
Llusern Scientific is a university spinout developing rapid molecular diagnostic test systems for human and animal healthcare. Its flagship product, Lodestar DX, delivers accurate diagnostic results in thirty five minutes to help combat antibiotic resistance.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Llusern Scientific's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
EH
Emma Hayhurst
Chief Executive
JN
Jeroen Nieuwland
Jeroen serves as chief scientific officer at Llusern Scientific, having previously directed the organisation. His background includes research roles at Cardiff University and the University of Cambridge, alongside a senior lectureship at the University of South Wales.
LinkedInAR
Ali Roula
Professor
Ali brings academic and technical leadership in biomedical engineering, alongside industry experience as chief technology officer at Llusern Scientific. He holds a PhD in computer science focused on machine vision in diagnostics.
LinkedIn
Martyn Lewis
Martyn currently serves as chief executive officer at Llusern Scientific, following earlier roles as managing director and commercial director at the firm. He previously held senior sales and marketing positions at EKF Diagnostics.
LinkedIn